首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

Journal of Neuroimmune Pharmacology
ISSN：1557-1890

Journal of Neuroimmune Pharmacology

J NEUROIMMUNE PHARM
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：较慢,6-12周
新锐分区：医学3区
年发文量：56
影响因子：3.5
JCR分区：Q2

基本信息

《神经免疫药理学杂志》的宗旨是促进神经系统药理学和免疫学新发现的传播、兴趣和交流。其目标与神经免疫药理学学会的目标相一致，即增加对受免疫系统影响的神经和神经精神疾病的基本了解，反之亦然，并采取药理学措施，以更好地了解疾病机制或改善疾病结局。JNIP的范围包括所有的主要工作和审查的病因学，预防和治疗的神经免疫和神经系统疾病的免疫失调的影响。我们欢迎对环境或内源性信号（如毒素和滥用药物、激素和细胞因子）的神经免疫调节进行原创性研究。JNIP将作为跨学科信息的可靠来源，桥接药理学、免疫学和神经科学领域。
1557-1890SCIE/Scopus收录
3.5
点击查看最新影响趋势>
5.9
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
NEUROSCIENCES 神经科学
3区
PHARMACOLOGY & PHARMACY 药学
2区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：NEUROSCIENCES
SCIE
Q2
109/314
学科：PHARMACOLOGY & PHARMACY
SCIE
Q2
107/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：NEUROSCIENCES
SCIE
Q1
77/314
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
70/353
64
56
点击查看年发文量趋势图>
7%-较慢,6-12周-医学-神经科学
2.9%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
92.86%32.14%5.41%
CiteScore：9.50
SJR：1.251
SNIP：0.991
学科类别分区排名百分位
大类：Neuroscience
小类：Neuroscience (miscellaneous)
Q1
2 / 60
大类：Neuroscience
小类：Pharmacology
Q1
42 / 321
大类：Neuroscience
小类：Immunology and Allergy
Q1
43 / 231
大类：Neuroscience
小类：Immunology
Q1
49 / 240

期刊高被引文献

Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09873-y
Proteomic Profiling of Exosomes Derived from Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09853-2
Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09851-4
Targeting the Dopaminergic System in Autoimmunity
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09834-5
Resveratrol (3, 5, 4′-Trihydroxy-trans-Stilbene) Attenuates a Mouse Model of Multiple Sclerosis by Altering the miR-124/Sphingosine Kinase 1 Axis in Encephalitogenic T Cells in the Brain
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09842-5
Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09884-9
Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09835-4
Intranasal Delivery of lincRNA-Cox2 siRNA Loaded Extracellular Vesicles Decreases Lipopolysaccharide-Induced Microglial Proliferation in Mice
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09864-z
HIV-1 Tat-Induced Astrocytic Extracellular Vesicle miR-7 Impairs Synaptic Architecture
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09869-8
Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09875-w
Stem Cell Extracellular Vesicles and their Potential to Contribute to the Repair of Damaged CNS Cells
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09865-y
Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09848-z
Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-018-09831-0
β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09891-w
Antiretroviral Drugs Promote Amyloidogenesis by De-Acidifying Endolysosomes
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09862-1
Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09839-0
Inhibitory Control Deficits Associated with Upregulation of CB1R in the HIV-1 Tat Transgenic Mouse Model of Hand
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09867-w
Transmigration of Tetraspanin 2 (Tspan2) siRNA Via Microglia Derived Exosomes across the Blood Brain Barrier Modifies the Production of Immune Mediators by Microglia Cells
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09895-6
Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09854-1
Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09852-3
Dopaminergic Agents in Rheumatoid Arthritis
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09850-5
The Role of β-Blockers in Melanoma
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09876-9
Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09856-z
Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09866-x
Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09885-8
Protease Inhibitors, Saquinavir and Darunavir, Inhibit Oligodendrocyte Maturation: Implications for Lysosomal Stress
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09893-8
Involvement of Interferon Regulatory Factor 7 in Nicotine’s Suppression of Antiviral Immune Responses
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09845-2
Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09900-y
Heroin Abuse and/or HIV Infection Dysregulate Plasma Exosomal miRNAs
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09892-9
Dopaminergic Pathways in Obesity-Associated Inflammation
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09863-0
The Association of Immune Markers with Cognitive Performance in South African HIV-Positive Patients
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09870-1
Protective Effects of 1-Methylnicotinamide on Aβ1–42-Induced Cognitive Deficits, Neuroinflammation and Apoptosis in Mice
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-018-09830-1
Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09897-4
Histamine Induces Microglia Activation and the Release of Proinflammatory Mediators in Rat Brain Via H1R or H4R
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09887-6
Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09883-w
Treg Cells Attenuate Neuroinflammation and Protect Neurons in a Mouse Model of Parkinson’s Disease
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09888-5
Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09894-7
Hemorrhage Associated Mechanisms of Neuroinflammation in Experimental Traumatic Brain Injury
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09882-x
Changes of Serum IgG Dimer Levels after Treatment with IVIg in Guillain-Barré Syndrome
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09871-0
Overexpression of TIPE2, a Negative Regulator of Innate and Adaptive Immunity, Attenuates Cognitive Deficits in APP/PS1 Mice
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09861-2
Chronic Intrahippocampal Infusion of HIV-1 Neurotoxic Proteins: A Novel Mouse Model of HIV-1 Associated Inflammation and Neural Stem Cell Dysfunction
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09846-1
Can Our Guts Tell Us Anything About MS?
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09841-6
Haloperidol Reduces the Activity of Complement and Induces the Anti-Inflammatory Transformation of Peritoneal Macrophages in Rats
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09860-3
Dissociable Contributions of Precuneus and Cerebellum to Subjective and Objective Neuropathy in HIV
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09837-2
Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates Neuroinflammation
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09872-z
Pre-exposure Prophylaxis Therapy and the Blood-Brain Barrier: Is PrEP Neuroprotective?
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09898-3
Editor’s Commentary for Special Issue: “The Role of Macrophages in HIV Persistence”
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09836-3
Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe?
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09881-y
The 25th Scientific Conference of the Society on Neuroimmune Pharmacology: Program and Abstracts
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09847-0
Successful Treatment of Long Standing Complex Regional Pain Syndrome with Hyperbaric Oxygen Therapy
来源期刊：Journal of Neuroimmune PharmacologyDOI：10.1007/s11481-019-09901-x

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学3区
NEUROSCIENCES 神经科学
3区
PHARMACOLOGY & PHARMACY 药学
2区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
NEUROSCIENCES 神经科学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
NEUROSCIENCES 神经科学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
否